$140.05 meals Payment -- Roche/Genentech to Dr. Elizabeth Roberts
Roche/Genentech provides $140.05 meal payment to Hematologist Dr. Roberts for Eylea-related activities.
This page provides a detailed analysis of a $140.05 meals payment from Roche/Genentech to Dr. Elizabeth Roberts. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $140.05 |
| Payment Type | meals |
| Payment Nature | Food and Beverage |
| Pharmaceutical Company | Roche/Genentech |
| Physician | Dr. Elizabeth Roberts |
| NPI Number | 1074366593 |
| Physician Specialty | Hematology |
| Location | Ann Arbor, MI |
| Date of Payment | 2025-12-26 |
| Related Drug/Device | Eylea |
| Conflict Assessment | Low -- Routine |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Roche/Genentech made a $140.05 meals payment to Elizabeth Roberts, a Hematology specialist in Ann Arbor, MI. The payment was associated with Eylea. This record details a $140.05 payment for "Food and Beverage" from Roche/Genentech to Dr. Elizabeth Roberts, a Hematology specialist. The payment was made on December 26, 2025, and is associated with the drug Eylea. The payment was categorized as a "meal" and occurred in Ann Arbor, MI.
Patient Guidance: What This Payment Means for You
This payment was for food and beverages provided by a pharmaceutical company. It is important to understand the nature of such payments and how they might relate to medical decisions. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Meals provided by pharmaceutical companies to physicians are common, but the context of this specific payment to a Hematologist regarding Eylea warrants further review to ensure alignment with standard practices for this specialty and drug.
Regulatory Context: Sunshine Act Requirements
Payments from manufacturers to physicians must be reported under the Open Payments program to ensure transparency and prevent potential conflicts of interest.
Related Topics
This payment is related to the following healthcare transparency topics:
- meals
- food-and-beverage
- roche-genentech
- elysta
- hematology
- physician-payment
Understanding meals Payments
Food and beverage payments cover meals provided to physicians during pharmaceutical sales representative visits, medical conferences, and educational events. While individual meal payments tend to be small (often under $100), research published in JAMA Internal Medicine has shown that even modest meals can be associated with changes in prescribing behavior. Meal payments are the most common type of pharmaceutical payment to physicians.
Frequently Asked Questions About This Payment
What was this $140.05 payment for?
This was a meals payment of $140.05 from Roche/Genentech to Elizabeth Roberts, categorized as "Food and Beverage". It was associated with Eylea. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Elizabeth Roberts accept pharmaceutical money?
Yes, Elizabeth Roberts received this $140.05 payment from Roche/Genentech. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Elizabeth Roberts's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this meals payment?
A meals payment of $140.05 is generally routine and common in the industry. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Hematology?
To compare this payment against Hematology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Hematology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Elizabeth Roberts's relationship with Roche/Genentech?
The payment amount is relatively small, suggesting it might be for a single meal or a small group. This $140.05 meals payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Hematology?
The payment is linked to Eylea, a drug commonly used in ophthalmology and oncology, though Dr. Roberts' specialty is Hematology.
What should patients do after learning about this payment?
This payment was for food and beverages provided by a pharmaceutical company. It is important to understand the nature of such payments and how they might relate to medical decisions.
What else should I know about this meals payment?
The payment date is in the future (2025-12-26), which is unusual for a completed transaction.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.